Skip to content

Investor Relations / SEC Filings

SEC Filings

Filing date Form Filer Description View
SC 13D/A FIL LTD

An amendment to a SC 13D filing

View HTML

Copyright Morningstar

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation